Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells-Reference-Cited by-同舟云学术

Effective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells

Published:2014-12 Issue:2 Volume:155 Page:160-175
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Wang Yao,Zhang Wen-ying,Han Qing-wang,Liu Yang,Dai Han-ren,Guo Ye-lei,Bo Jian,Fan Hui,Zhang Yan,Zhang Ya-jing,Chen Mei-xia,Feng Kai-chao,Wang Quan-shun,Fu Xiao-bing,Han Wei-dong

Funder

National Natural Science Foundation of China

National Basic Science and Development Programme of China

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project;Blood,1997

2. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research;Jaffe;Hematol. Educ. Program Am. Soc. Hematol. Am. Soc. Hematol. Educ. Program,2009

3. Anti-CD20 antibody therapy for B-cell lymphomas;Maloney;N. Engl. J. Med.,2012

4. Diffuse large B-cell lymphoma: current strategies and future directions;Cultrera;Cancer Control,2012

5. Adoptive immunotherapy for cancer;Ruella;Immunol. Rev.,2014

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements and Challenges in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

2. Activated CD4<sup>+</sup> T Cell Proportion in the Peripheral Blood Correlates with the Duration of Cytokine Release Syndrome and Predicts Clinical Outcome after Chimeric Antigen Receptor T Cell Therapy;Internal Medicine;2024-07-01

3. Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion;Cellular Oncology;2024-04-25

4. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy;Frontiers in Immunology;2024-03-12

5. The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management;Advanced Pharmaceutical Bulletin;2024-03-10